Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting senescence as an anticancer therapy
Laura Bousset, Jesús Gil
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3855-3880
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 148
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Saurav Kumar Jha, Gabriele De Rubis, Shankar Raj Devkota, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102315-102315
Open Access | Times Cited: 31
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
Mariantonietta D’Ambrosio, Jesús Gil
Developmental Cell (2023) Vol. 58, Iss. 12, pp. 1007-1021
Open Access | Times Cited: 41
Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death
Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 388-388
Open Access | Times Cited: 14
Combined targeting of senescent cells and senescent macrophages: A new idea for integrated treatment of lung cancer
Ming Gu, Yang Liu, Wenhui Zheng, et al.
Seminars in Cancer Biology (2024) Vol. 106-107, pp. 43-57
Closed Access | Times Cited: 11
Senescence as a therapeutic target in cancer and age-related diseases
Domhnall McHugh, Imanol Durán, Jesús Gil
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 57-71
Closed Access | Times Cited: 9
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers
Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 581-581
Open Access | Times Cited: 18
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Tareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188994-188994
Closed Access | Times Cited: 18
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
Emma Cuttini, Camilla Goi, Ester Pellarin, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Birong Jiang, Wei Zhang, Xuguang Zhang, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 58-73
Open Access | Times Cited: 7
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
Yue Liu, Isabelle Lomeli, Stephen J. Kron
Cells (2024) Vol. 13, Iss. 15, pp. 1281-1281
Open Access | Times Cited: 7
Epithelial–mesenchymal transition to Mitigate Age-Related Progression in Lung Cancer
Riya Thapa, Saurabh Gupta, Gaurav Gupta, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102576-102576
Closed Access | Times Cited: 6
MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action
Neeta Somaiah, William D. Tap
Cancer Treatment Reviews (2023) Vol. 122, pp. 102668-102668
Open Access | Times Cited: 15
Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy
Mohammad Alsalem, Amr Ellaithy, Sarah Bloukh, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 1
Closed Access | Times Cited: 5
Therapy-induced cellular senescence: Potentiating tumor elimination or driving cancer resistance and recurrence?
Yue Liu, Isabelle Lomeli, Stephen J. Kron
(2024)
Open Access | Times Cited: 5
D-MAINS: A Deep-Learning Model for the Label-Free Detection of Mitosis, Apoptosis, Interphase, Necrosis, and Senescence in Cancer Cells
Sarah He, Muhammed Sillah, Aidan R. Cole, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1004-1004
Open Access | Times Cited: 5
The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities
Zehua Wang, Chen Chen, Jiaoyu Ai, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies
Júlia López, Àngela Llop‐Hernández, Sara Verdura, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Exosomal Dynamics: Bridging the Gap Between Cellular Senescence and Cancer Therapy
Babu Santha Aswani, Anjana Sajeev, Mangala Hegde, et al.
Mechanisms of Ageing and Development (2025) Vol. 225, pp. 112045-112045
Open Access
Cellular oxidative stress and sirtuins mediate regulation of senescence and neuronal differentiation by withaferin A
Keshava Prasad, Sunil C. Kaul, Renu Wadhwa, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Advancements in antibody-drug conjugates as cancer therapeutics
Jung Yin Fong, Zhixin Phuna, D. Chong, et al.
Journal of the National Cancer Center (2025)
Open Access
The Potential of Senescence as a Target for Developing Anticancer Therapy
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3436-3436
Open Access | Times Cited: 10
Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma
Madhura Ketkar, Sanket Desai, Pranav Rana, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 2027-2043
Closed Access | Times Cited: 3
Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K/AKT/mTOR pathway
Thatsanapong Pongking, Kitti Intuyod, Phonpilas Thongpon, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 622-634
Open Access | Times Cited: 3
Therapy-induced senescence is finally escapable, what is next?
Tareq Saleh
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 713-721
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top